Here, we report a case who developed peripheral edema related to paroxetine discontinuation and whose peripheral edema disappeared after resumption of the paroxetine treatment.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Paroxetine is a selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic characteristics.
📊
Temel Bulgular & Veri:In association with paroxetine cessation, certain side effects can be observed frequently, including dizziness, vertigo, nausea, vomiting, headache, anxiety, insomnia, and irritability.
💡
Sonuç & Katkı:Here, we report a case who developed peripheral edema related to paroxetine discontinuation and whose peripheral edema disappeared after resumption of the paroxetine treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Paroxetine is a selective serotonin reuptake inhibitor (SSRI), with antidepressant and anxiolytic characteristics. In association with paroxetine cessation, certain side effects can be observed frequently, including dizziness, vertigo, nausea, vomiting, headache, anxiety, insomnia, and irritability. Paroxetine-induced peripheral edema has been reported. However, there has been no report on peripheral edema related to paroxetine cessation. Here, we report a case who developed peripheral edema related to paroxetine discontinuation and whose peripheral edema disappeared after resumption of the paroxetine treatment.
🔖
Bu Makaleye Atıf Yap
MERMİ, O., ATMACA, M. (2022). Peripheral edema related to paroxetine discontinuation: a case report. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 3, 291–294. https://ajindex.com/articles/573979
Pae CU, Patkar AA. Paroxetine: current status in psychiatry. Expert Rev Neurother 2007;7(2):107-20. [CrossRef] Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994;9(Suppl.1):S19-S26. [CrossRef] Feighner JP. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients. Int Clin Psychopharmacol 1992;6(Suppl. 4):S31-S5. [CrossRef] Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000;25(3):255-61.
Hariri AG, Ceylan ME. Depression Medication: Specific serotonin reuptake inhibitors. Mood Disorders Series 2003;1(7):339-45. (Turkish) Dadic-Hero E, Ruzic K, Grahovac T, Graovac M, Palijan TZ, Sepic-Grahovac D. Allergic reactions outcome of sertraline and escitalopram treatments. Psychiatr Danub 2011;23(1):120-2.
Balci G, Tikir B, Goka E. Peripheral edema associated with trazodone: a case report. Klinik Psikofarmakoloji Bulteni - Bulletin of Clinical Psychopharmacology 2012;22(Suppl.1):S68. (Turkish) Cam B, Kurt H. Peripheral edema associated with mirtazapine: a case report. Anadolu Psikiyatri Derg 2013;14(1):84-6. (Turkish) [CrossRef] Uguz F. Rapid weight gain associated with edema after use of paroxetine and venlafaxine: 2 case reports. Clin Neuropharmacol 2014;37(1):34-5. [CrossRef] Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occuring on withdrawal. Br J Clin Pharmacol 1996;42(6):757- 63. [CrossRef] Masdrakis VG, Oulis P, Kouzoupis AV, Masdrakis GV, Soldatos CR. Bilateral ankle oedema in a patient taking escitalopram. World J Biol Psychiatry 2009;10(4 Pt 3):939-41. [CrossRef] Ravi PB, Ravishankar GM, Andrade C. Bilateral peripheral edema as a rare adverse effect of escitalopram. Indian J Psychiatry 2014;56(1):97. [CrossRef] Kutscher EC, Lund BC, Hartman BA. Peripheral edema associated with mirtazapine. Ann Pharmacother 2001;35(11):1494-5. [CrossRef] Kuchel O, Hamet P, Cuche JL, Tolis G, Fraysse J, Genest J. Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema. J Clin Endocrinol Metab 1975;41(2):282-9. [CrossRef] Uguz F, Sahingoz M, Kose SA, Ozbebit O, Sengul C, Selvi Y, et al. Antidepressants and menstruation disorders in women: a cross-sectional study in three centers. Gen Hosp Psychiatry 2012;34(